Kim HJ - Search Results

1

Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells.

Jung CG, Kim HJ, Miron VE, Cook S, Kennedy TE, Foster CA, Antel JP, Soliven B. Jung CG, et al. Among authors: kim hj. Glia. 2007 Dec;55(16):1656-67. doi: 10.1002/glia.20576. Glia. 2007. PMID: 17876806

2

Persistence of immune responses to altered and native myelin antigens in patients with multiple sclerosis treated with altered peptide ligand.

Kim HJ, Antel JP, Duquette P, Alleva DG, Conlon PJ, Bar-Or A. Kim HJ, et al. Clin Immunol. 2002 Aug;104(2):105-14. doi: 10.1006/clim.2002.5258. Clin Immunol. 2002. PMID: 12165271 Clinical Trial.

3

Inflammatory potential and migratory capacities across human brain endothelial cells of distinct glatiramer acetate-reactive T cells generated in treated multiple sclerosis patients.

Kim HJ, Biernacki K, Prat A, Antel JP, Bar-Or A. Kim HJ, et al. Clin Immunol. 2004 Apr;111(1):38-46. doi: 10.1016/j.clim.2004.01.004. Clin Immunol. 2004. PMID: 15093550

4

Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis.

Kim HJ, Ifergan I, Antel JP, Seguin R, Duddy M, Lapierre Y, Jalili F, Bar-Or A. Kim HJ, et al. J Immunol. 2004 Jun 1;172(11):7144-53. doi: 10.4049/jimmunol.172.11.7144. J Immunol. 2004. PMID: 15153538

5

Natalizumab effects on immune cell responses in multiple sclerosis.

Niino M, Bodner C, Simard ML, Alatab S, Gano D, Kim HJ, Trigueiro M, Racicot D, Guérette C, Antel JP, Fournier A, Grand'Maison F, Bar-Or A. Niino M, et al. Among authors: kim hj. Ann Neurol. 2006 May;59(5):748-54. doi: 10.1002/ana.20859. Ann Neurol. 2006. PMID: 16634035 Clinical Trial.

6

Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation.

Darlington PJ, Touil T, Doucet JS, Gaucher D, Zeidan J, Gauchat D, Corsini R, Kim HJ, Duddy M, Jalili F, Arbour N, Kebir H, Chen J, Arnold DL, Bowman M, Antel J, Prat A, Freedman MS, Atkins H, Sekaly R, Cheynier R, Bar-Or A; Canadian MS/BMT Study Group. Darlington PJ, et al. Among authors: kim hj. Ann Neurol. 2013 Mar;73(3):341-54. doi: 10.1002/ana.23784. Epub 2013 Mar 5. Ann Neurol. 2013. PMID: 23463494

7

Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis.

Duddy M, Niino M, Adatia F, Hebert S, Freedman M, Atkins H, Kim HJ, Bar-Or A. Duddy M, et al. Among authors: kim hj. J Immunol. 2007 May 15;178(10):6092-9. doi: 10.4049/jimmunol.178.10.6092. J Immunol. 2007. PMID: 17475834

8

Efficacy and safety of mitoxantrone in patients with highly relapsing neuromyelitis optica.

Kim SH, Kim W, Park MS, Sohn EH, Li XF, Kim HJ. Kim SH, et al. Among authors: kim w, kim hj. Arch Neurol. 2011 Apr;68(4):473-9. doi: 10.1001/archneurol.2010.322. Epub 2010 Dec 13. Arch Neurol. 2011. PMID: 21149806

9

New insights into neuromyelitis optica.

Kim W, Kim SH, Kim HJ. Kim W, et al. Among authors: kim hj, kim sh. J Clin Neurol. 2011 Sep;7(3):115-27. doi: 10.3988/jcn.2011.7.3.115. Epub 2011 Sep 29. J Clin Neurol. 2011. PMID: 22087205 Free PMC article.

10

Central nervous system aquaporin-4 autoimmunity presenting with an isolated cerebral abnormality.

Kim SH, Kim W, Kook MC, Hong EK, Kim HJ. Kim SH, et al. Among authors: kim w, kim hj. Mult Scler. 2012 Sep;18(9):1340-3. doi: 10.1177/1352458512441271. Epub 2012 Jul 3. Mult Scler. 2012. PMID: 22760103

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,811 results

Search Page

Filters